Report      Database

    Personalized Medicine Diagnostics (Flow Cytometry, Sepsis Immunos, Routine Coagulation, Psychiatric Disorders, Tumor Markers, Molecular Blood Typing and Other Testing) Market & Forecast

    Date: 13 Jun, 2013              Type: Life Science              Pages: 173

    Personalized Medicine Diagnostics (Flow Cytometry, Sepsis Immunos, Routine Coagulation, Psychiatric Disorders, Tumor Markers, Molecular Blood Typing and Other Testing) Market & Forecast
    • Electronic Access - Single User License
      $1,400.00
    • CD-ROM Mail Delivery
      $1,500.00
    • Hard-copy Mail Delivery
      $1,550.00
    • Electronic Access - Multi User License
      $2,200.00

    Personalized Medicine Diagnostics - Market Overview
     
    Personalized Medicine is often defined as “the right treatment for the right person at the right time.” Personalized medicine is becoming the place to be in clinical diagnostics as well and slowly becoming the reality of future in the diagnostics industry
     
    By Technology Segment - Personalized Medicine diagnostics market is expected to grow with a double digit CAGR for the period of 2013 to 2018. It is expected that personalized medicine diagnostics market by technology is going to double by 2018 from its current market size in 2012. In this segment, Point of Care Testing and Molecular Diagnostics segments control the #1 and #2 positions in 2012.
     
    By Diseases Segment - Personalized Medicine diagnostics market is expected to be more than US$ 30 Billion by 2018. Diabetes management test and Cancer management test are the leading market in this segment. 
     
    Renub Research report entitled “Personalized Medicine Diagnostics (Flow Cytometry, Sepsis Immunos, Routine Coagulation, Psychiatric Disorders, Tumor Markers, Molecular Blood Typing and Other Testing)” report provides a comprehensive analysis of the emerging personalized medicine diagnostic market segments, including their dynamics, size, market share, key investors, clinical trials statement, technological trends, company analysis and a realistic future potential for personalized medicine in clinical testing. The report also entails major drivers and challenges of personalized medicine diagnostic market. This 173 page report contains 94 Figures and 16 Tables studies the Personalized Medicine Diagnostics Market. This report contains 12 chapters 
     
    • Chapter 1 is Executive Summary
     
    • Chapter 2 contains worldwide personalized medicine diagnostic market & forecast (2011 – 2018). The market includes technological & disease-wise personalized medicine diagnostics market
     
    • Chapter 3 contains worldwide personalized medicine diagnostic market share segment. Segment include Technology, Disease-Wise
     
    • Chapter 4 contains segment-wise technological personalized diagnostic market & forecast (2010 - 2018)
     
    • Chapter 5 contains geographical segment-wise personalized diagnostic market & forecast (2011 - 2018)
     
    • Chapter 6 contains disease-wise personalized diagnostic market share & forecast (2011 - 2018) 
     
    • Chapter 7 contains disease-wise personalized diagnostic market & forecast (2011 - 2018)
     
    • Chapter 8 and 9 contains clinical trial statement and key investors in Personalized Diagnostics Medicine Market 
     
    • Chapter 10 and 11 contains growth Drivers & Challenges for Personalized Medicine 
     
    • Chapter 12 contains company analysis of Personalized Medicine  
      
    Companies analyzed in this report are:
     
    HistoRx 
    A&G Pharmaceuticals Inc 
    20/20 GeneSystems 
    Tethys Bioscience 
    Genomas Inc
      
    Data Sources
     
    This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Renub Research team of industry experts.
     
    Primary sources include industry surveys and telephone interviews with industry experts. 
     
    Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Government Agencies, Magazines, Newspapers, Trade associations, Books, Industry Portals, Industry Associations and access to more than 500 paid databases. 

    1. Executive Summary
     
    2. Worldwide Personalized Medicine Diagnostic Market & Forecast
    2.1 By Technology – Worldwide Personalized Medicine Diagnostic Market & Forecast
    2.2 By Diseases – Worldwide Personalized Medicine Diagnostic Market & Forecast
     
    3. Worldwide – Personalized Medicine Diagnostic Market Share Segment
    3.1 By Technology – Worldwide Personalized Medicine Diagnostic Market Share & Forecast
    3.2 By Disease – Worldwide Personalized Medicine Diagnostic Market Share & Forecast
     
    4. By Technology – Personalized Medicine Diagnostic Market & Forecast
    4.1 Worldwide – Pharmacogenetics Market & Forecast
    4.2 Worldwide – Pharmacogenomics Market & Forecast
    4.3 Worldwide – SNP Genotyping Market & Forecast
    4.4 Worldwide – Pharmacoproteomics Market & Forecast
    4.5 Worldwide – Biochips Market & Forecast
    4.6 Worldwide – Point of Care Test Market & Forecast
    4.7 Worldwide – Molecular Diagnostics Market & Forecast
    4.8 Worldwide – Genetic Screening Market & Forecast
     
    5. By Geographical Segmentation – Personalized Medicine Diagnostic Market & Forecast
    5.1 North America – Personalized Medicine Diagnostic Market & Forecast
    5.2 Western Europe (EU5) – Personalized Medicine Diagnostic Market & Forecast
     
    6. By Disease – Personalized Medicine Diagnostic Market Share & Forecast
    6.1 Worldwide – Cardiovascular Management Test Market Share & Forecast
    6.2 Worldwide – Diabetes Management Test Market Share & Forecast
    6.3 Worldwide – Coagulation Test Market Share & Forecast
    6.4 Worldwide – Cancer Management Test Market Share & Forecast
    6.5 Worldwide – Infectious Diseases Test Market Share & Forecast
     
    7. By Disease – Personalized Medicine Diagnostic Market & Forecast
    7.1 Worldwide – Cardiovascular Management Test Market & Forecast
     
    7.2 Worldwide – Cardiovascular Management Test Market & Forecast (By Segment) 

    7.2.1 Cardiac Marker Immunoassays Market & Forecast
    7.2.2 Cardiac Risk Markers Market & Forecast
    7.2.3 Cardiac Markers Molecular Test Market & Forecast
     
    7.3 Worldwide – Diabetes Management Test Market & Forecast
     
    7.4 Worldwide – Diabetes Management Test Market & Forecast (By Segment) 

    7.4.1 Blood Glucose Monitoring Market & Forecast
    7.4.2 Hemoglobin A1C (HbA1c) Test Market & Forecast
     
    7.5 Worldwide – Coagulation Test Market & Forecast
     
    7.6 Worldwide – Coagulation Test Market & Forecast (By Segment) 

    7.6.1 Routine Coagulation Test Market & Forecast
    7.6.2 Molecular Coagulation Test Market & Forecast
     
    7.7 Worldwide – Cancer Management Test Market & Forecast
     
    7.8 Worldwide – Cancer Management Test Market & Forecast (By Segment) 

    7.8.1 Pharmacodiagnostic Histology Test Market & Forecast
    7.8.2 Flow Cytometry Market & Forecast
    7.8.3 Tumor Markers Market & Forecast
    7.8.4 Human Papillomavirus (HPV) Test Market & Forecast
    7.8.5 Molecular Assays Market & Forecast
    7.8.6 Circulating Tumor Cells Market & Forecast
     
    7.9 Worldwide – Infectious Diseases Test Market & Forecast
     
    7.10 Worldwide – Infectious Diseases Test Market (By Segment) 

    7.10.1 Human Immunodeficiency Virus (HIV) CD4 Count Market & Forecast
    7.10.2 Human Immunodeficiency Virus (HIV) Viral Load Test Market & Forecast
    7.10.3 Hepatitis C (HCV) Viral Load Test Market & Forecast
    7.10.4 Hepatitis B (HBV) Viral Load Test Market & Forecast
    7.10.5 Hospital Acquired Infections (HAI) Molecular Test Market & Forecast
    7.10.6 Sepsis Immunos Test Market & Forecast
    7.10.7 Multi Drug Resistant Tuberculosis (MDR-TB) Test Market & Forecast
     
    7.11 Worldwide – Microbiology Identification/ Antibiotic Sensitivity Test (ID/AST) Market & Forecast
    7.12 Worldwide – Psychiatric Disorders Test Market & Forecast
    7.13 Worldwide – Transplant Tissue Typing (HLA) Test Market & Forecast
    7.14 Worldwide – Molecular Blood Typing Market & Forecast

     
    8. Personalized Medicine Clinical Trial Statement
    8.1 Biomarker Research for Personalized Medicine in Blood Cancer Patient
    8.2 Genetic & Environmental Determinants of Immune Phenotype Variance: Establishing a Path towards Personalized Medicine
    8.3 Warfarin Adverse Event Reduction for Adults Receiving Genetic Testing at Therapy Initiation (WARFARIN) 
    8.4 Genetic Analysis for Personalized Medicine for Morbid Obesity
    8.5 Pharmacogenomics for Antidepressant Guidance & Education
    8.6 I-SPY 2 Trial (Investigation of Serial Studies to Predict your Therapeutic Response with Imaging & Molecular Analysis) 
    8.7 Genetic Mechanisms in Human Hypertension RAAS Inhibition Study
    8.8 Open Label Study for the Functional Characterization of Drug Metabolism and Transport
    8.9 Personalized Therapy in Non-Small Cell Lung Cancer
    8.10 A Pilot Study of Personalized Medicine for Pediatric Asthma
     
    9. Key Investors in Personalized Medicine Market
     
    10. Key Drivers (Opportunities) of Growth in Personalized Medicine Diagnostic Market
    10.1 Government Agencies Shaping Personalized Medicine Diagnostic Market
    10.2 Organizations will Profit Together, Not Alone in the Personalized Medicine
    10.3 The Blockbuster Model of One Drug Fits all is under Pressure
     
    11. Challenges in Personalized Medicine Diagnostic Market
    11.1 Reimbursement Policy & Regulatory Framework
    11.2 Regulatory Framework
    11.3 Payers Worry That Cost of Personalized Medicine Could Be Unsustainable
     
    12. Company Analysis
    12.1 HistoRx

    12.1.1 Focus/Market Served
    12.1.2 Outlook/ Strategy for Success
    12.1.3 Products
     
    12.2 A&G Pharmaceutical, Inc
    12.2.1 Focus/Market Served
    12.2.2 Outlook/Strategy for Success
    12.2.3 Products
     
    12.3 20/20 GeneSystems
    12.3.1 Focus/Market Served
    12.3.2 Outlook/Strategy for Success
    12.3.3 Products
     
    12.4 Tethys Bioscience
    12.4.1 Focus/Market Served
    12.4.2 Outlook/Strategy for Success
    12.4.3 Products
     
    12.5 Genomas, Inc. 
    12.5.1 Focus/Market Served
    12.5.2 Products 

    List of Figures:
     
    Figure 2 1: Worldwide – By Technology Personalized Medicine Diagnostic Market (Million US$), 2010 – 2012
    Figure 2 2: Worldwide – Forecast for By Technology Personalized Medicine Diagnostic Market (Million US$), 2013 – 2018
    Figure 2 3: Worldwide – By Diseases Personalized Medicine Diagnostic Market (Million US$), 2011 – 2012
    Figure 2 4: Worldwide – Forecast for By Diseases Personalized Medicine Diagnostic Market (Million US$), 2013 – 2018
     
    Figure 3 1: Worldwide – By Technology Personalized Medicine Diagnostic Market Share (Percent), 2010 – 2012
    Figure 3 2: Worldwide – Forecast for By Technology Personalized Medicine Diagnostic Market Share (Percent), 2013 – 2018
     
    Figure 4 1: Worldwide – Pharmacogenetics Market (Million US$), 2010 – 2012
    Figure 4 2: Worldwide – Forecast for Pharmacogenetics Market (Million US$), 2013 – 2018
    Figure 4 3: Worldwide – Pharmacogenomics Market (Million US$), 2010 – 2012
    Figure 4 4: Worldwide – Forecast for Pharmacogenomics Market (Million US$), 2013 – 2018
    Figure 4 5: Worldwide – SNP Genotyping Market (Million US$), 2010 – 2012
    Figure 4 6: Worldwide – Forecast for SNP Genotyping Market (Million US$), 2013 – 2018
    Figure 4 7: Worldwide – Pharmacoproteomics Market (Million US$), 2010 – 2012
    Figure 4 8: Worldwide – Forecast for Pharmacoproteomics Market (Million US$), 2013 – 2018
    Figure 4 9: Worldwide – Biochips Market (Million US$), 2010 – 2012
    Figure 4 10: Worldwide – Forecast for Biochips Market (Million US$), 2013 – 2018
    Figure 4 11: Worldwide – Point of Care Testing Market (Million US$), 2009 – 2012
    Figure 4 12: Worldwide – Forecast for Point of Care Testing Market (Million US$), 2013 – 2018
    Figure 4 13: Worldwide – Molecular Diagnostics Market (Million US$), 2010 – 2012
    Figure 4 14: Worldwide – Forecast for Molecular Diagnostics Market (Million US$), 2013 – 2018
    Figure 4 15: Worldwide – Genetic Screening Market (Million US$), 2010 – 2012
    Figure 4 16: Worldwide – Forecast for Genetic Screening Market (Million US$), 2013 – 2018
     
    Figure 5 1: North America – Personalized Medicine Diagnostic Market (Million US$), 2011 – 2012
    Figure 5 2: North America – Forecast for Personalized Medicine Diagnostic Market (Million US$), 2013 – 2018
    Figure 5 3: Western Europe (EU-5) – Personalized Medicine Diagnostic Market (Million US$), 2011 – 2012
    Figure 5 4: Western Europe (EU-5) – Forecast for Personalized Medicine Diagnostic Market (Million US$), 2013 – 2018
     
    Figure 6 1: Worldwide – Cardiovascular Management Test Market Share (Percent), 2011 – 2012
    Figure 6 2: Worldwide – Forecast for Cardiovascular Management Test Market Share (Percent), 2013 – 2018
    Figure 6 3: Worldwide – Diabetes Management Test Market Share (Percent), 2011 – 2012
    Figure 6 4: Worldwide – Forecast for Diabetes Management Test Market Share (Percent), 2013 – 2018
    Figure 6 5: Worldwide – Coagulation Test Market Share (Percent), 2011 – 2012
    Figure 6 6: Worldwide – Forecast for Coagulation Test Market Share (Percent), 2013 – 2018
    Figure 6 7: Worldwide – Cancer Management Test Market Share (Percent), 2011 – 2012
    Figure 6 8: Worldwide – Forecast for Cancer Management Test Market Share (Percent), 2013 – 2018
    Figure 6 9: Worldwide – Infectious Diseases Test Market Share (Percent), 2011 – 2012
    Figure 6 10: Worldwide – Forecast for Infectious Diseases Test Market Share (Percent), 2013 – 2018
     
    Figure 7 1: Worldwide – Cardiovascular Management Test Market (Million US$), 2011 – 2012
    Figure 7 2: Worldwide – Forecast for Cardiovascular Management Test Market (Million US$), 2013 – 2018
    Figure 7 3: Worldwide – Cardiac Marker Immunoassays Market (Million US$), 2011 – 2012
    Figure 7 4: Worldwide – Forecast for Cardiac Marker Immunoassays Market (Million US$), 2013 – 2018
    Figure 7 5: Worldwide – Cardiac Risk Markers Market (Million US$), 2011 – 2012
    Figure 7 6: Worldwide – Forecast for Cardiac Risk Markers Market (Million US$), 2013 – 2018
    Figure 7 7: Worldwide – Cardiac Markers Molecular Test Market (Million US$), 2011 – 2012
    Figure 7 8: Worldwide – Forecast for Cardiac Markers Molecular Test Market (Million US$), 2013 – 2018
    Figure 7 9: Worldwide – Diabetes Management Test Market (Million US$), 2011 – 2012
    Figure 7 10: Worldwide – Forecast for Diabetes Management Test Market (Million US$), 2013 – 2018
    Figure 7 11: Worldwide – Blood Glucose Monitoring Market (Million US$), 2011 – 2012
    Figure 7 12: Worldwide – Forecast for Blood Glucose Monitoring Market (Million US$), 2013 – 2018
    Figure 7 13: Worldwide – Hemoglobin A1C (HbA1c) Test Market (Million US$), 2011 – 2012
    Figure 7 14: Worldwide – Forecast for Hemoglobin A1C (HbA1c) Test Market (Million US$), 2013 – 2018
    Figure 7 15: Worldwide – Coagulation Test Market (Million US$), 2011 – 2012
    Figure 7 16: Worldwide – Forecast for Coagulation Test Market (Million US$), 2013 – 2018
    Figure 7 17: Worldwide – Routine Coagulation Test Market (Million US$), 2011 – 2012
    Figure 7 18: Worldwide – Forecast for Routine Coagulation Test Market (Million US$), 2013 – 2018
    Figure 7 19: Worldwide – Molecular Coagulation Test Market (Million US$), 2011 – 2012
    Figure 7 20: Worldwide – Forecast for Molecular Coagulation Test Market (Million US$), 2013 – 2018
    Figure 7 21: Worldwide – Cancer Management Test Market (Million US$), 2011 – 2012
    Figure 7 22: Worldwide – Forecast for Cancer Management Test Market (Million US$), 2013 – 2018
    Figure 7 23: Worldwide – Pharmacognostic Histology Test Market (Million US$), 2011 – 2012
    Figure 7 24: Worldwide – Forecast for Pharmacognostic Histology Test Market (Million US$), 2013 – 2018
    Figure 7 25: Worldwide – Flow Cytometry Market (Million US$), 2011 – 2012
    Figure 7 26: Worldwide – Forecast for Flow Cytometry Market (Million US$), 2013 – 2018
    Figure 7 27: Worldwide – Tumor Markers Market (Million US$), 2011 – 2012
    Figure 7 28: Worldwide – Forecast for Tumor Markers Market (Million US$), 2013 – 2018
    Figure 7 29: Worldwide – Human Papillomavirus (HPV) Test Market (Million US$), 2011 – 2012
    Figure 7 30: Worldwide – Forecast for Human Papillomavirus (HPV) Test Market (Million US$), 2013 – 2018
    Figure 7 31: Worldwide – Molecular Assays Market (Million US$), 2011 – 2012
    Figure 7 32: Worldwide – Forecast for Molecular Assays Market (Million US$), 2013 – 2018
    Figure 7 33: Worldwide – Circulating Tumor Cells Market (Million US$), 2011 – 2012
    Figure 7 34: Worldwide – Forecast for Circulating Tumor Cells Market (Million US$), 2013 – 2018
    Figure 7 35: Worldwide – Infectious Diseases Test Market (Million US$), 2011 – 2012
    Figure 7 36: Worldwide – Forecast for Infectious Diseases Test Market (Million US$), 2013 – 2018
    Figure 7 37: Worldwide – HIV CD4 Count Market (Million US$), 2011 – 2012
    Figure 7 38: Worldwide – Forecast for HIV CD4 Count Market (Million US$), 2013 – 2018
    Figure 7 39: Worldwide – HIV Viral Load Test Market (Million US$), 2011 – 2012
    Figure 7 40: Worldwide – Forecast for HIV Viral Load Test Market (Million US$), 2013 – 2018
    Figure 7 41: Worldwide – HCV Viral Load Test Market (Million US$), 2011 – 2012
    Figure 7 42: Worldwide – Forecast for HCV Viral Load Test Market (Million US$), 2013 – 2018
    Figure 7 43: Worldwide – HBV Viral Load Test Market (Million US$), 2011 – 2012
    Figure 7 44: Worldwide – Forecast for HBV Viral Load Test Market (Million US$), 2013 – 2018
    Figure 7 45: Worldwide – HAI Molecular Test Market (Million US$), 2011 – 2012
    Figure 7 46: Worldwide – Forecast for HAI Molecular Test Market (Million US$), 2013 – 2018
    Figure 7 47: Worldwide – Sepsis Immunos Test Market (Million US$), 2011 – 2012
    Figure 7 48: Worldwide – Forecast for Sepsis Immunos Test Market (Million US$), 2013 – 2018
    Figure 7 49: Worldwide – Multi Drug Resistant Tuberculosis (MDR-TB) Market (Million US$), 2011 – 2012
    Figure 7 50: Worldwide – Forecast for Multi Drug Resistant Tuberculosis (MDR-TB) Market (Million US$), 2013 – 2018
    Figure 7 51: Worldwide – Microbiology ID/AST Market (Million US$), 2011 – 2012
    Figure 7 52: Worldwide – Forecast for Microbiology ID/AST Market (Million US$), 2013 – 2018
    Figure 7 53: Worldwide – Psychiatric Disorders Test Market (Million US$), 2011 – 2012
    Figure 7 54: Worldwide – Forecast for Psychiatric Disorders Test Market (Million US$), 2013 – 2018
    Figure 7 55: Worldwide – Transplant Tissue Typing (HLA) Test Market (Million US$), 2011 – 2012
    Figure 7 56: Worldwide – Forecast for Transplant Tissue Typing (HLA) Test Market (Million US$), 2013 – 2018
    Figure 7 57: Worldwide – Molecular Blood Typing Market (Million US$), 2011 – 2012
    Figure 7 58: Worldwide – Forecast for Molecular Blood Typing Market (Million US$), 2013 – 2018
     
     
    List of Tables:
     
    Table 3 1: Worldwide – By Diseases Personalized Medicine Diagnostic Market Share (Percent), 2011 – 2012
    Table 3 2: Worldwide – Forecast for By Diseases Personalized Medicine Diagnostic Market Share (Percent), 2013 – 2018
     
    Table 7 1:  Selected Human Papillomavirus (HPV) Tests, 2011
    Table 7 2: Selected Molecular Personalized Medicine Tests in Cancer, 2011
     
    Table 8 1: Clinical Trial – Biomarker Research for Personalized Medicine in Blood Cancer Patient
    Table 8 2: Clinical Trial – Genetic & Environmental Determinants of Immune Phenotype Variance: Establishing a Path Towards Personalized Medicine
    Table 8 3: Clinical Trial – Warfarin Adverse Event Reduction for Adults Receiving Genetic Testing at Therapy Initiation
    Table 8 4: Clinical Trial – Genetic Analysis for Personalized Medicine for Morbid Obesity
    Table 8 5: Clinical Trial – Pharmacogenomics for Antidepressant Guidance & Education
    Table 8 6: Clinical Trial – I-SPY 2 Trial (Investigation of Serial Studies to Predict Your Therapeutic Response with Imaging & molecular Analysis) 
    Table 8 7: Clinical Trial – Genetic Mechanisms in Human Hypertension RAAS Inhibition Study
    Table 8 8: Clinical Trial – Open Label Study for the Functional Characterization of Drug Metabolism and Transport
    Table 8 9: Clinical Trial – Personalized Therapy in Non-small Cell Lung Cancer
    Table 8 10: Clinical Trial – A Pilot Study of Personalized Medicine for Pediatric Asthma
     
    Table 9 1: Key Investors in Personalized Medicine, 2011 & 2012 
     
    Table 12 1: Partnership & Alliance Models in Personalized Medicine


    Related Products